BIO-key International
BKYI
4 hedge funds and large institutions have $644K invested in BIO-key International in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
3.47% more ownership
Funds ownership: 0% → 3.47% (+3.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$294K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$252K |
| 3 |
Millennium Management
New York
|
+$115K |
| 4 |
Goldman Sachs
New York
|
+$55.1K |
Top Sellers
BKYI Hedge Fund Activity: Q3 2017 in Review
4 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q3 2017, worth a combined $644K.
Buyers outnumbered sellers: 4 funds opened new BKYI positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Perkins Capital Management, opening a new position worth an estimated $294K.
- 4 institutional investors held BIO-key International (BKYI) as of Q3 2017, up from 0 in Q2 2017.
- Funds reported $644K of BIO-key International stock for Q3 2017.
- 4 funds opened new BIO-key International positions in Q3 2017 and 0 closed out, a net change of +4 holders.
- The largest BIO-key International buyer in Q3 2017 was Perkins Capital Management, an estimated $294K added.
Based on aggregated 13F filings for Q3 2017.